Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers

Clinical trial NCT07743593 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07743593
Sponsor: University of Minnesota
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cryptococcal Antigenemia HIV-1-infection Cryptococcal Infection Cryptococcal Meningitis

Start date: 2026-09-01
Primary completion: 2031-08-30
Enrollment: 505

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.